Saponin-Rich Extracts and Their Acid Hydrolysates Differentially Target Colorectal Cancer Metabolism in the Frame of Precision Nutrition

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Nov 20

PMID 33212825

Citations 7

Authors

Marta Gomez de Cedron

Joaquin Navarro Del Hierro

Marina Reguero

Sonia Wagner

Adrian Bouzas

Adriana Quijada-Freire

Guillermo Reglero

Diana Martin

Ana Ramirez de Molina

Affiliations

Soon will be listed here.

Abstract

Saponins or their aglycone form, sapogenin, have recently gained interest as bioactive agents due to their biological activities, their antitumoral effects being among them. Metabolic reprogramming has been recognized as a hallmark of cancer and, together with the increased aerobic glycolysis and glutaminolysis, the altered lipid metabolism is considered crucial to support cancer initiation and progression. The purpose of this study was to assess and compare the inhibitory effects on colorectal cancer cell lines of saponin-rich extracts from fenugreek and quinoa (FE and QE, respectively) and their hydrolyzed extracts as sapogenin-rich extracts (HFE and HQE, respectively). By mean of the latest technology in the analysis of cell bioenergetics, we demonstrate that FE and HFE diminished mitochondrial oxidative phosphorylation and aerobic glycolysis; meanwhile, quinoa extracts did not show relevant activities. Distinct molecular mechanisms were identified for fenugreek: FE inhibited the expression of and , synergizing with the chemotherapeutic drug 5-fluorouracil (5-FU); meanwhile, HFE inhibited lipid metabolism targets, leading to diminished intracellular lipid content. The relevance of considering the coexisting compounds of the extracts or their hydrolysis transformation as innovative strategies to augment the therapeutic potential of the extracts, and the specific subgroup of patients where each extract would be more beneficial, are discussed in the frame of precision nutrition.

Citing Articles

Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits.

Gomez de Cedron M, Moreno-Rubio J, de la O Pascual V, Alvarez B, Villarino M, Sereno M Front Immunol. 2025; 16:1519978.

PMID: 40034703 PMC: 11872936. DOI: 10.3389/fimmu.2025.1519978.

Study on the Effect of Quinoa Saponins on Human Colon Cancer HT-29 Cells.

Shang H, Sun J, Zheng Z, Sun S, Yan X Food Sci Nutr. 2025; 13(1):e4669.

PMID: 39803233 PMC: 11717042. DOI: 10.1002/fsn3.4669.

Harnessing the Potential of Quinoa: Nutritional Profiling, Bioactive Components, and Implications for Health Promotion.

Xi X, Fan G, Xue H, Peng S, Huang W, Zhan J Antioxidants (Basel). 2024; 13(7).

PMID: 39061898 PMC: 11273950. DOI: 10.3390/antiox13070829.

Microbiome-driven anticancer therapy: A step forward from natural products.

Guan Y, Wu D, Wang H, Liu N mLife. 2024; 3(2):219-230.

PMID: 38948147 PMC: 11211674. DOI: 10.1002/mlf2.12118.

Willd. and L.: Ancestral Andean Food Security and Modern Anticancer and Antimicrobial Activity.

Romero-Benavides J, Guaraca-Pino E, Duarte-Casar R, Rojas-Le-Fort M, Bailon-Moscoso N Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139854 PMC: 10747716. DOI: 10.3390/ph16121728.

References

Aguirre-Portoles C, Feliu J, Reglero G, Ramirez de Molina A . ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone. Mol Oncol. 2018; 12(10):1735-1752. PMC: 6166002. DOI: 10.1002/1878-0261.12367. View

Garcia-Estevez L, Moreno-Bueno G . Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res. 2019; 21(1):35. PMC: 6397485. DOI: 10.1186/s13058-019-1124-1. View

Sanchez-Martinez R, Cruz-Gil S, Gomez de Cedron M, Alvarez-Fernandez M, Vargas T, Molina S . A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy. Oncotarget. 2015; 6(36):38719-36. PMC: 4770732. DOI: 10.18632/oncotarget.5340. View

Brown K, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A . The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018; 118(8):1130-1141. PMC: 5931106. DOI: 10.1038/s41416-018-0029-6. View

Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, Mendiola M . 3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients. PLoS One. 2016; 11(12):e0168423. PMC: 5167383. DOI: 10.1371/journal.pone.0168423. View

Chen H, Qin S, Wang M, Zhang T, Zhang S . Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis. Sci Rep. 2015; 5:8243. PMC: 4316166. DOI: 10.1038/srep08243. View

Navarro Del Hierro J, Reglero G, Martin D . Chemical Characterization and Bioaccessibility of Bioactive Compounds from Saponin-Rich Extracts and Their Acid-Hydrolysates Obtained from Fenugreek and Quinoa. Foods. 2020; 9(9). PMC: 7555840. DOI: 10.3390/foods9091159. View

Gonzalez-Vallinas M, Molina S, Vicente G, Zarza V, Martin-Hernandez R, Garcia-Risco M . Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer. PLoS One. 2014; 9(6):e98556. PMC: 4043684. DOI: 10.1371/journal.pone.0098556. View

Sparano J, Wang M, Zhao F, Stearns V, Martino S, Ligibel J . Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. 2012; 118(23):5937-46. PMC: 3586227. DOI: 10.1002/cncr.27527. View

10.

Gonzalez-Vallinas M, Molina S, Vicente G, de la Cueva A, Vargas T, Santoyo S . Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res. 2013; 72:61-8. DOI: 10.1016/j.phrs.2013.03.010. View

11.

Peck B, Schulze A . Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment. Trends Cancer. 2019; 5(11):693-703. DOI: 10.1016/j.trecan.2019.09.007. View

12.

Parkin D, Boyd L, Walker L . 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011; 105 Suppl 2:S77-81. PMC: 3252065. DOI: 10.1038/bjc.2011.489. View

13.

Liu Q, Luo Q, Halim A, Song G . Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer. Cancer Lett. 2017; 401:39-45. DOI: 10.1016/j.canlet.2017.05.002. View

14.

Kristo A, Klimis-Zacas D, Sikalidis A . Protective Role of Dietary Berries in Cancer. Antioxidants (Basel). 2016; 5(4). PMC: 5187535. DOI: 10.3390/antiox5040037. View

15.

Ziberna L, Samec D, Mocan A, Nabavi S, Bishayee A, Farooqi A . Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy. Int J Mol Sci. 2017; 18(3). PMC: 5372655. DOI: 10.3390/ijms18030643. View

16.

Van Raay T, Allen-Vercoe E . Microbial Interactions and Interventions in Colorectal Cancer. Microbiol Spectr. 2017; 5(3). PMC: 11687491. DOI: 10.1128/microbiolspec.BAD-0004-2016. View

17.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

18.

Gomez de Cedron M, Mouhid L, Garcia-Carrascosa E, Fornari T, Reglero G, Ramirez de Molina A . as Potential Co-adjuvant in Pancreatic Cancer: The Energetic Catastrophe Induced via BMP8B Ends Up With Autophagy-Induced Cell Death. Front Bioeng Biotechnol. 2020; 7:455. PMC: 6992545. DOI: 10.3389/fbioe.2019.00455. View

19.

Kuzu O, Noory M, Robertson G . The Role of Cholesterol in Cancer. Cancer Res. 2016; 76(8):2063-70. PMC: 5813477. DOI: 10.1158/0008-5472.CAN-15-2613. View

20.

Guclu-Ustundag O, Mazza G . Saponins: properties, applications and processing. Crit Rev Food Sci Nutr. 2007; 47(3):231-58. DOI: 10.1080/10408390600698197. View